Paul Gardephe
- All
- News
-
Indian-Origin Portfolio Manager Ordered to Begin 9 Year Term
Martoma, 40, was ordered by US District Judge Paul Gardephe to surrender by Thursday afternoon, after he lost his bid last week to remain free on bail pending appeal of his conviction.
-
Indian-Origin Manager Loses Bid to Stay out of Jail
An Indian-origin portfolio manager, sentenced to nine years for his role in the most lucrative insider trading scheme in US history, has lost his bid to stay out of jail after a judge ruled that evidence against him was "overwhelming", weeks before he has to start his prison term.
-
Indian-Origin Fund Manager Martoma's Bid for New Trial Denied by Court
A bid for acquittal and fresh trial filed by an Indian-origin portfolio manager, convicted for an insider trading scheme in the US, has been denied by a court which ruled that evidence in the case "overwhelmingly" showed that he is guilty.
-
Indian-origin fund manager Martoma to face trial for insider trading
An Indian-origin former hedge fund portfolio manager will face trial in a federal court here for allegedly participating in one of the "most lucrative" insider trading schemes worth $276 million involving information about clinical trials for an Alzheimer's drug.
-
Indian-Origin Portfolio Manager Ordered to Begin 9 Year Term
Martoma, 40, was ordered by US District Judge Paul Gardephe to surrender by Thursday afternoon, after he lost his bid last week to remain free on bail pending appeal of his conviction.
-
Indian-Origin Manager Loses Bid to Stay out of Jail
An Indian-origin portfolio manager, sentenced to nine years for his role in the most lucrative insider trading scheme in US history, has lost his bid to stay out of jail after a judge ruled that evidence against him was "overwhelming", weeks before he has to start his prison term.
-
Indian-Origin Fund Manager Martoma's Bid for New Trial Denied by Court
A bid for acquittal and fresh trial filed by an Indian-origin portfolio manager, convicted for an insider trading scheme in the US, has been denied by a court which ruled that evidence in the case "overwhelmingly" showed that he is guilty.
-
Indian-origin fund manager Martoma to face trial for insider trading
An Indian-origin former hedge fund portfolio manager will face trial in a federal court here for allegedly participating in one of the "most lucrative" insider trading schemes worth $276 million involving information about clinical trials for an Alzheimer's drug.
